Genus plc Reports Strong First Half Performance and Strategic Advances

Genus plc ( (GB:GNS) ) just unveiled an announcement.

Genus plc reported a strong financial performance for the first half of the fiscal year, with a 19% increase in adjusted operating profit and a 21% rise in adjusted profit before tax. The company achieved significant cash generation and maintained its interim dividend. Strategic progress was noted in the porcine sector with new customer wins in China and advancements in gene editing technology, while the bovine sector saw improvements through the Value Acceleration Programme. Genus expects continued growth, although geopolitical and currency challenges remain.

More about Genus plc

Genus plc is a biotechnology company that specializes in animal breeding and genetic improvement, primarily serving the dairy, beef, and pork food production sectors. The company operates globally, selling products such as semen, embryos, and breeding animals with superior genetics under the trademarks ‘ABS’ for cattle and ‘PIC’ for pigs. Genus is headquartered in Basingstoke, UK, with operations in over 24 countries and research labs in Madison, Wisconsin, USA.

YTD Price Performance: 15.23%

Average Trading Volume: 129,101

Technical Sentiment Consensus Rating: Buy

Current Market Cap: £1.17B

Find detailed analytics on GNS stock on TipRanks’ Stock Analysis page.